Callan Family Office’s Coherent COHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$11.3M Sell
47,579
-6,612
-12% -$1.51M 0.26% 80
2025
Q4
$10M Buy
54,191
+1,988
+4% +$297K 0.21% 91
2025
Q3
$5.62M Sell
52,203
-1,285
-2% -$128K 0.18% 132
2025
Q2
$4.77M Buy
53,488
+37,513
+235% +$2.7M 0.15% 158
2025
Q1
$1.04M Sell
15,975
-1,494
-9% -$124K 0.08% 212
2024
Q4
$1.65M Buy
+17,469
New +$1.75M 0.11% 171
2023
Q2
Sell
-10,700
Closed -$407K 122
2023
Q1
$407K Buy
+10,700
New +$435K 0.1% 106

Other funds holding COHR

Callan Family Office's COHR Position: Q1 2026 in Review

Callan Family Office reduced its Coherent (COHR) stake by 12% in Q1 2026, selling an estimated $1.51M and leaving 47,579 shares worth $11.3M. The position accounts for 0.26% of the portfolio, ranked #80.

Callan Family Office first reported a position in COHR in Q1 2023 and has held it in 7 quarters since. 1,100 funds tracked by Wall St. Rank hold COHR as of Q1 2026.

  • Callan Family Office held 47,579 shares of Coherent worth $11.3M as of Q1 2026.
  • Callan Family Office sold 6,612 Coherent shares in Q1 2026, an estimated $1.51M.
  • Coherent made up 0.26% of Callan Family Office's portfolio in Q1 2026, its #80 holding.
  • Callan Family Office first reported a position in Coherent in Q1 2023 and has held it in 7 quarters since.
  • 1,100 funds tracked by Wall St. Rank held Coherent as of Q1 2026.

Based on Callan Family Office's 13F filing for Q1 2026, filed 13 May 2026.